-
KDNY Dashboard
- Financials
- Filings
-
Holdings
-
Transcripts
-
ETFs
- Insider
- Institutional
- Shorts
Chinook Therapeutics (KDNY)
Company Profile
Quarter (USD) | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 129.22 mm | 129.22 mm | 129.22 mm | 129.22 mm | 129.22 mm | 129.22 mm |
Cash burn (monthly) | (no burn) | 1.56 mm | 24.21 mm | 20.97 mm | 20.40 mm | 14.50 mm |
Cash used (since last report) | n/a | 30.15 mm | 466.50 mm | 404.07 mm | 393.08 mm | 279.42 mm |
Cash remaining | n/a | 99.07 mm | -337.28 mm | -274.85 mm | -263.85 mm | -150.20 mm |
Runway (months of cash) | n/a | 63.3 | -13.9 | -13.1 | -12.9 | -10.4 |
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 0 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 76.52 mm |
Total shares | 4.20 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Vivo Capital IX | 4.18 mm | $76.37 mm |
Morningside Venture | 12.08 k | $150.00 k |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
11 Aug 23 | Azelby Robert | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 7,000 | 0.00 | 0 |
11 Aug 23 | Azelby Robert | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 18.4 | 28,200 | 518.88 k | 0 |
11 Aug 23 | Dobmeier Eric | Common Stock | Sale back to company | Dispose D | No | No | 0 | 301,138 | 0.00 | 0 |
11 Aug 23 | Dobmeier Eric | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 11,300 | 0.00 | 0 |
11 Aug 23 | Dobmeier Eric | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 64,050 | 0.00 | 0 |
11 Aug 23 | Dobmeier Eric | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 50,001 | 0.00 | 0 |
11 Aug 23 | Dobmeier Eric | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 20,248 | 0.00 | 0 |
11 Aug 23 | Dobmeier Eric | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 30,797 | 0.00 | 0 |
11 Aug 23 | Dobmeier Eric | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 14.73 | 255,150 | 3.76 mm | 0 |
11 Aug 23 | Dobmeier Eric | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 27.1 | 300,000 | 8.13 mm | 0 |